Retrophin, Inc. Underwriting Agreements
7 Contracts & Agreements
- Underwriting Agreement, dated February 28, 2023, by and among Travere Therapeutics, Inc., Jefferies LLC, J.P. Morgan Securities LLC, BofA Securities, Inc. and SVB Securities LLC (Filed With SEC on March 1, 2023)
- Underwriting Agreement, dated March 8, 2022, by and among the Company, Jefferies LLC, SVB Securities LLC, BofA Securities, Inc. and Evercore Group L.L.C (Filed With SEC on March 11, 2022)
- Underwriting Agreement, dated February 11, 2021, by and among Travere Therapeutics, Inc., BofA Securities, Inc., Jefferies LLC and SVB Leerink LLC, as representatives of the... (Filed With SEC on February 12, 2021)
- Underwriting Agreement, dated June 8, 2020, by and among Retrophin, Inc., Jefferies LLC, Barclays Capital Inc. and BofA Securities, Inc., as representatives of the several... (Filed With SEC on June 9, 2020)
- Underwriting Agreement, dated September 5, 2018, by and among the Company, Jefferies LLC, and Barclays Capital Inc (Filed With SEC on September 10, 2018)
- 6,840,000 Shares RETROPHIN, INC. CommonStock, Par Value $0.0001 Per Share UNDERWRITING AGREEMENT (Filed With SEC on March 19, 2015)
- 4,820,000 Shares Retrophin, Inc. UNDERWRITING AGREEMENT (Filed With SEC on January 7, 2014)
